# Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation

> **NCT03234920** · NA · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 22 (actual)

## Conditions studied

- Sarcopenia

## Interventions

- **DIETARY_SUPPLEMENT:** BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03234920
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-25
- **Primary completion:** 2018-09-15
- **Final completion:** 2018-09-15
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03234920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03234920, "Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03234920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*